Business
US biotech Novavax could make COVID vaccine onshore in Australia – Sydney Morning Herald
The company behind Australia’s third major coronavirus vaccine candidate says it would be happy to set up shop in Australia, just like its competitor Moderna.
American biotechnology company Novavax has outlined plans to make doses of its coronavirus vaccine in Australia after revealing it is searching for a manufacturing partner to produce its protein-based jab onshore.
The federal government has ordered 51 million doses of Novavaxs product, which is still awaiting regulatory clearances in the US and Australia. In an interview with The Sydney Morning Herald and The Age, Novavaxs chief commercial officer John Trizzino said the company has had early conversations…
-
Business15 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
General24 hours agoLiberals dump NSW candidate who said women should not serve in ADF combat
-
Business11 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General21 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts